Cargando…
Progress in the Discovery of Treatments for C. difficile Infection: A Clinical and Medicinal Chemistry Review
Clostridium difficile is an anaerobic, Gram-positive pathogen that causes C. difficile infection, which results in significant morbidity and mortality. The incidence of C. difficile infection in developed countries has become increasingly high due to the emergence of newer epidemic strains, a growin...
Autores principales: | Tsutsumi, Lissa S., Owusu, Yaw B., Hurdle, Julian G., Sun, Dianqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3921470/ https://www.ncbi.nlm.nih.gov/pubmed/24236721 http://dx.doi.org/10.2174/1568026613666131113154753 |
Ejemplares similares
-
In vivo evaluation of Clostridioides difficile enoyl-ACP reductase II (FabK) Inhibition by phenylimidazole unveils a promising narrow-spectrum antimicrobial strategy
por: Dureja, Chetna, et al.
Publicado: (2023) -
Reduced Susceptibility to Metronidazole Is Associated With Initial Clinical Failure in Clostridioides difficile Infection
por: Gonzales-Luna, Anne J, et al.
Publicado: (2021) -
Burger's medicinal chemistry and drug discovery
Publicado: (1996) -
Synthesis, Structure–Activity Relationship Studies, and Antibacterial Evaluation of 4-Chromanones and Chalcones, as Well as Olympicin A and Derivatives
por: Feng, Li, et al.
Publicado: (2014) -
Genetic Mechanisms of Vancomycin Resistance in Clostridioides difficile: A Systematic Review
por: Eubank, Taryn A., et al.
Publicado: (2022)